CLINICAL RESEARCH
What We Bring to the Table
SITE NETWORK
Bridge Hospitals & Investigator Sites
We connect international sponsors and CROs with qualified oncology departments, hospital networks, and principal investigators across MENA and Africa — experienced in GCP-compliant trial conduct for solid tumours and haematological malignancies.
Solid Tumours - Leukaemia
CRO PARTNERSHIPS
Local CROs & Global Network Bridge
Local contract research organisations with regional expertise are central to successful trial execution. We act as the strategic bridge between local CROs and global medical networks — providing regulatory guidance, logistics coordination, and pharmacovigilance support.
CRO Liaison - Regulatory Support - PV Integration
STUDY SUPPORT
Phase III–IV Full Study Operations
From first-in-human Phase II s to large-scale Phase IV post-marketing surveillance — our operational infrastructure, proprietary SOP framework, and GCP-trained network supports the full spectrum of oncology clinical research.
Phase III - Phase IV / PMSR
ONCOLOGY FOCUS
Solid Tumours &
Leukaemia
STUDY PHASES SUPPORTED
GCP ICH Compliant
Open For Proposals
CLINICAL RESEARCH
Clinical Studies & Research Collaboration
Why Africa — Why Now
A Continent of Untapped Research Potential
Many African countries carry a significant and growing cancer burden — yet remain dramatically underrepresented in international clinical trials. This creates a unique scientific opportunity: large, treatment-naïve patient populations with diverse genetic profiles that can meaningfully accelerate drug development and broaden trial data.
ITC Pharma GmbH has established the operational environment, regulatory expertise, and healthcare network to facilitate oncology studies across the region — connecting global sponsors with qualified sites, local investigators, and logistics support.
Proposals welcome from Pharma Companies · Academic Centres · CROs · Diagnostic Laboratories · Bridge Hospitals
CLINICAL RESEARCH
Open for Proposals &
Collaboration
We welcome proposals from pharmaceutical companies, academic medical centres, and global CROs seeking to conduct oncology studies in Africa and the MENA region. Whether you are looking for investigator sites, molecular diagnostic partners, patient recruitment support, or regulatory navigation — ITC Pharma GmbH is your trusted operational gateway.
Laboratories specialising in genetic aberration identification and targeted therapy biomarker selection are particularly encouraged to reach out —
your expertise is a cornerstone of precision oncology study design.
Pharma Sponsors
Phase III–IV study funding and protocol design
Bridge Hospitals
Investigator sites & patient access across Africa
Local CROs
Regional trial execution & regulatory navigation
